HIT Consultant
SEPTEMBER 5, 2023
What You Should Know: – Integral , an innovator in safeguarding privacy and maximizing data quality raises $6.9M in seed funding to protect sensitive health data and provide automated expert certification software that enables health and life sciences companies access to compliant, rich, de-identified data in hours, rather than months.
Healthcare It News
OCTOBER 7, 2021
"This limited access to groundbreaking treatments and being part of the system of science to improve treatments for future patients is the other side of the problem." " One of the major reasons clinical trial-matching and recruitment is so slow is that it's largely limited by laws and regulations related to patient privacy.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
HIT Consultant
JANUARY 4, 2022
Fortune 50 companies already use Replica’s technology to enable fast and effective access to high utility, synthetic versions of health data across their organizations while meeting regulatory obligations and compliance with privacy laws like the Health Insurance Portability and Accountability Act (HIPAA) in the U.S.
HIT Consultant
DECEMBER 22, 2023
By taking a minimalist approach to data collection, companies not only reduce the amount of sensitive information at risk but also simplify data management. This approach aligns with the principle of data minimization, a key aspect of privacy regulations like the General Data Protection Regulation (GDPR) and HIPAA.
Health Populi
AUGUST 12, 2021
During the first year of the COVID-19 pandemic, the health care sector was profoundly affected by cyber-attacks on connected devices, we learn in the report, Rise of the Machines 2021: State of Connected Devices – IT, IoT, IoMT and OT from Ordr. What’s unclear is how public policy and regulation can/will meet this moment.
HIT Consultant
NOVEMBER 9, 2022
“Healthcare is at a crossroads, facing unprecedented pressure and disruption — including affordability challenges, shifting patient expectations, and an increasing deluge of health data,” said Tim Durst, a managing director at Accenture who leads the global medical technology sector in the company’s Life Sciences practice.
HIT Consultant
SEPTEMBER 14, 2021
Along with advances in the availability and quality of real-world data (RWD) from sources like electronic health records (EHRs) , registries, medical claims and pharmacy data, the Cures Act has been a catalyst for increased emphasis on using RWE in clinical and regulatory decision-making.
Expert insights. Personalized for you.
52 
Let's personalize your content